Bridging the Sciences: Advances in HIV, Viral Hepatitis and Emerging Viruses

Credit: NIAID
(credit: NIAID)

Outstanding French and American researchers and key opinion leaders will gather for a high-level, one-day scientific symposium on human viral infections. Interactive sessions will present basic and clinic research focusing on advances in virology, therapeutic drug development and practical considerations for management of clinically relevant viruses including HIV, hepatitis B and C (HBV, HCV), and other emerging viruses (e.g., Zika, Ebola, Dengue, and Chikungunya). Participants will be updated on key features of these human viral infections, their epidemiology, pathophysiology, and virology, as well as on emerging preventive and therapeutic strategies.

This symposium is co-organized by Office for Science and Technology of the Embassy of France to the United States,  Emory University and its Department of Pediatrics

Click here to see the conference agenda: Bridging the Sciences Conference Agenda

When: October  26 | 8:50 a.m. – 7:00 p.m.
Where: Emory University Conference Center (1615 Clifton Rd, Atlanta, GA 30329)
Registration: $50 registration fee for non-students; $10 for students/Post-Doc. To register click here

Dr. Raymond F. Schinazi is the Frances Winship Walters Professor of Pediatrics and Director of the Laboratory of Biochemical Pharmacology at Emory University and co-Director of the HIV Cure Scientific Working Group for the NIH-sponsored Emory University CFAR. He has authored over 550 papers and 7 books and holds over 100 issued US patents, which have resulted in 16 New Drug Applications (NDA). Dr. Schinazi is a world leader in nucleoside chemistry and best known for his pioneering work on HIV, HBV and HCV US FDA approved drugs d4T (stavudine), 3TC (lamivudine), FTC (emtricitabine), LdT (telbivudine), and sofosbuvir (Sovaldi).


This France-Atlanta event is made possible with the support of: